Copyright Reports & Markets. All rights reserved.

Global Lower GI Series Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Lower GI Series Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Lower GI Series Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Double-Contrast
    • 1.4.3 Single-Contrast
  • 1.5 Market by Application
    • 1.5.1 Global Lower GI Series Market Share by Application: 2020 VS 2026
    • 1.5.2 Gastroenteritis
    • 1.5.3 Colon Polyps
    • 1.5.4 Tumor
    • 1.5.5 Strictures Crohn's Disease
    • 1.5.6 Ulcerative Colitis
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Lower GI Series Market Perspective (2015-2026)
  • 2.2 Global Lower GI Series Growth Trends by Regions
    • 2.2.1 Lower GI Series Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lower GI Series Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lower GI Series Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Lower GI Series Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Lower GI Series Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Lower GI Series Players by Market Size
    • 3.1.1 Global Top Lower GI Series Players by Revenue (2015-2020)
    • 3.1.2 Global Lower GI Series Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Lower GI Series Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Lower GI Series Market Concentration Ratio
    • 3.2.1 Global Lower GI Series Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Lower GI Series Revenue in 2019
  • 3.3 Lower GI Series Key Players Head office and Area Served
  • 3.4 Key Players Lower GI Series Product Solution and Service
  • 3.5 Date of Enter into Lower GI Series Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Lower GI Series Historic Market Size by Type (2015-2020)
  • 4.2 Global Lower GI Series Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Lower GI Series Market Size by Application (2015-2020)
  • 5.2 Global Lower GI Series Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lower GI Series Market Size (2015-2020)
  • 6.2 Lower GI Series Key Players in North America (2019-2020)
  • 6.3 North America Lower GI Series Market Size by Type (2015-2020)
  • 6.4 North America Lower GI Series Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Lower GI Series Market Size (2015-2020)
  • 7.2 Lower GI Series Key Players in Europe (2019-2020)
  • 7.3 Europe Lower GI Series Market Size by Type (2015-2020)
  • 7.4 Europe Lower GI Series Market Size by Application (2015-2020)

8 China

  • 8.1 China Lower GI Series Market Size (2015-2020)
  • 8.2 Lower GI Series Key Players in China (2019-2020)
  • 8.3 China Lower GI Series Market Size by Type (2015-2020)
  • 8.4 China Lower GI Series Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Lower GI Series Market Size (2015-2020)
  • 9.2 Lower GI Series Key Players in Japan (2019-2020)
  • 9.3 Japan Lower GI Series Market Size by Type (2015-2020)
  • 9.4 Japan Lower GI Series Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Lower GI Series Market Size (2015-2020)
  • 10.2 Lower GI Series Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Lower GI Series Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Lower GI Series Market Size by Application (2015-2020)

11 India

  • 11.1 India Lower GI Series Market Size (2015-2020)
  • 11.2 Lower GI Series Key Players in India (2019-2020)
  • 11.3 India Lower GI Series Market Size by Type (2015-2020)
  • 11.4 India Lower GI Series Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Lower GI Series Market Size (2015-2020)
  • 12.2 Lower GI Series Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Lower GI Series Market Size by Type (2015-2020)
  • 12.4 Central & South America Lower GI Series Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Eisai
    • 13.1.1 Eisai Company Details
    • 13.1.2 Eisai Business Overview
    • 13.1.3 Eisai Lower GI Series Introduction
    • 13.1.4 Eisai Revenue in Lower GI Series Business (2015-2020))
    • 13.1.5 Eisai Recent Development
  • 13.2 Cadila Pharmaceuticals
    • 13.2.1 Cadila Pharmaceuticals Company Details
    • 13.2.2 Cadila Pharmaceuticals Business Overview
    • 13.2.3 Cadila Pharmaceuticals Lower GI Series Introduction
    • 13.2.4 Cadila Pharmaceuticals Revenue in Lower GI Series Business (2015-2020)
    • 13.2.5 Cadila Pharmaceuticals Recent Development
  • 13.3 Purdue Pharma
    • 13.3.1 Purdue Pharma Company Details
    • 13.3.2 Purdue Pharma Business Overview
    • 13.3.3 Purdue Pharma Lower GI Series Introduction
    • 13.3.4 Purdue Pharma Revenue in Lower GI Series Business (2015-2020)
    • 13.3.5 Purdue Pharma Recent Development
  • 13.4 Peacehealth
    • 13.4.1 Peacehealth Company Details
    • 13.4.2 Peacehealth Business Overview
    • 13.4.3 Peacehealth Lower GI Series Introduction
    • 13.4.4 Peacehealth Revenue in Lower GI Series Business (2015-2020)
    • 13.4.5 Peacehealth Recent Development
  • 13.5 Novadaq
    • 13.5.1 Novadaq Company Details
    • 13.5.2 Novadaq Business Overview
    • 13.5.3 Novadaq Lower GI Series Introduction
    • 13.5.4 Novadaq Revenue in Lower GI Series Business (2015-2020)
    • 13.5.5 Novadaq Recent Development
  • 13.6 Astrazeneca
    • 13.6.1 Astrazeneca Company Details
    • 13.6.2 Astrazeneca Business Overview
    • 13.6.3 Astrazeneca Lower GI Series Introduction
    • 13.6.4 Astrazeneca Revenue in Lower GI Series Business (2015-2020)
    • 13.6.5 Astrazeneca Recent Development
  • 13.7 Ironwood Pharmaceuticals
    • 13.7.1 Ironwood Pharmaceuticals Company Details
    • 13.7.2 Ironwood Pharmaceuticals Business Overview
    • 13.7.3 Ironwood Pharmaceuticals Lower GI Series Introduction
    • 13.7.4 Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2015-2020)
    • 13.7.5 Ironwood Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Lower GI Series market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lower GI Series market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Eisai
    Cadila Pharmaceuticals
    Purdue Pharma
    Peacehealth
    Novadaq
    Astrazeneca
    Ironwood Pharmaceuticals
    ...

    Market segment by Type, the product can be split into
    Double-Contrast
    Single-Contrast
    Market segment by Application, split into
    Gastroenteritis
    Colon Polyps
    Tumor
    Strictures Crohn's Disease
    Ulcerative Colitis
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now